| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 597,402 | 603,653 | 541,955 | 589,415 | | Cost of Revenue | 421,514 | 460,341 | 416,763 | 471,752 | | | Gross Profit | 175,888 | 143,312 | 125,192 | 117,663 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 131,335 | 111,743 | 11,361 | 52,918 | | Non Recurring | (6,379) | 3,306 |
-
| (5,503) | | Others | 13,899 | (37,903) | 66,124 | 15,394 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 37,033 | 66,166 | 47,707 | 54,854 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (6,464) | 32,008 | 1,890 | (149,379) | | Earnings Before Interest And Taxes | 30,569 | 98,174 | 49,597 | (94,525) | | Interest Expense | 19,910 | 19,024 | 20,890 | 19,698 | | Income Before Tax | 10,659 | 79,150 | 28,707 | (114,223) | | Income Tax Expense | 233 | 712 |
-
| 4,168 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 10,426 | 78,438 | 28,707 | (118,391) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 10,426 | 78,438 | 28,707 | (118,391) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $10,426 | $78,438 | $28,707 | ($118,391) |
|
0.51% Nasdaq 
Income Statement
